跳至主要内容
临床试验/ISRCTN33898123
ISRCTN33898123已完成不适用

A randomised double-blind placebo-controlled trial of preemptive analgesia with bupivacaine in patients undergoing mastectomy for carcinoma of the breast

Medical University of Gdansk (Poland)0 个研究点目标入组 100 人开始时间: 2010年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Breast cancer patients in disease stage I, II and IIIA without neoadjuvant treatment
  • 2. Patients qualified for radical modified mastectomy
  • 3. Informed consent obtained from the patient
  • 4. Females aged 35 - 90 years

排除标准

  • 1. No informed consent obtained from the patient
  • 2. Allergy to bupivacaine or any other local analgesic agent
  • 3. Allergy to any of the drugs used in the analgesia protocol
  • 4. Prior surgically treatment for breast cancer
  • 5. Patient history with treatment of chronic pain
  • 6. Patients with any psychiatric disorders
  • 7. Patients weight below 50 kg

研究者

发起方
Medical University of Gdansk (Poland)

相似试验

Preemptive analgesia with bupivacaine in mastectomy | 临床试验